Skip to main content

Nodule Solitary Pulmonary clinical trials at UC Cancer

2 research studies open to eligible people

Showing trials for
  • Biomarkers for Risk Stratification in Lung Cancer

    open to eligible people ages 40 years and up

    This is a prospective observational study that will follow patients who undergo lung cancer screening at the San Francisco VA Medical Center, University of California, San Francisco (UCSF) Medical Center, and the San Francisco General Hospital. The proposed study will comprise of two primary populations to determine the ctDNA assay performance in a variety of clinical settings.

    at UCSF

  • LungLB in Subjects Presenting With Indeterminate Pulmonary Nodules

    open to eligible people ages 40 years and up

    Correlate performance of LungLB Test with outcome of a scheduled biopsy.

    at UCLA

Our lead scientists for Nodule Solitary Pulmonary research studies include .

Last updated: